HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who started this subject	9/25/2000 5:33:37 AM
From: nigel bates	of 1022

ftmarketwatch.com{46B5826C-F90B-441D-B04C-0F1EED50D550} "LONDON (FTMW) -- Shares in German biotech firms MorphoSys AG [DE:663200] and GPC Biotech AG [DE:585150] rose on Monday after they announced the development of antibodies they hope to use in drugs to fight rejection in organ and bone-marrow transplants. GPC shares rose 9.5 percent to €63.50, and MorphoSys shares rose almost 6 percent to €215 in early trading on Germany’s Neuer Markt...."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next